Firefly Neuroscience and Zeto Team Up to Integrate EEG and AI
Firefly Neuroscience, Inc. (NASDAQ: AIFF), a company using Artificial Intelligence (AI) to improve brain health outcomes, has entered a strategic partnership with Zeto, Inc., known for its advances in EEG brain monitoring. The companies plan to connect Firefly’s Brain Network Analytics (BNA™) technology with Zeto’s FDA-cleared EEG systems so clinicians can access richer data, more easily, in more places. The aim is straightforward: make high-quality brain monitoring and analysis more accessible for healthcare providers and improve how neurological conditions are diagnosed and managed.
Transforming How EEG Data Reaches Clinicians
Under the agreement, Firefly becomes a non-exclusive distributor of Zeto’s EEG headset systems. In practice, this puts Zeto’s proven monitoring solutions—already in use at over 200 healthcare institutions nationwide—into Firefly’s channel, where they can be paired with BNA™ insights. It’s a distribution move with a clinical purpose: reduce friction, expand reach, and shorten the path from EEG recording to clinically useful analysis.
Deeper Insight for Patient Care
Jon Olsen, CEO of Firefly Neuroscience, framed the collaboration as a direct response to urgent needs in brain health. By combining Zeto’s hardware with Firefly’s BNA™ analytics, clinicians can gain a clearer picture of brain function across a range of neurological and mental health conditions. The promise is practical: better information for decision-making, tighter monitoring over time, and ultimately, more informed care plans that can improve patient outcomes.
EEG Access in the ICU, Clinic, and Beyond
Zeto’s EEG headsets, including WR19 and Zeto ONE, are built for ease of use so teams can deploy them in many clinical settings—from intensive care units to outpatient offices. A robust cloud platform supports this flexibility, enabling near real-time access to EEG data and streamlined storage. Clinicians can tap into support from neurologists around the country and use AI-assisted tools that help with seizure and epilepsy management. The devices are designed to be intuitive, which helps teams capture data promptly when it’s needed most.
Looking Ahead: Broader Reach, Smoother Workflows
Through this agreement, Firefly will offer Zeto’s EEG devices alongside Zeto’s cloud services to its customers. That means healthcare providers can set up monitoring, review EEG traces, and manage data and reports within one connected workflow. Real-time analysis and storage are part of the package, which is crucial when evaluating neurological disorders. As Firefly integrates its BNA™ technology, clinicians can expect an optimized diagnostic process and broader, more consistent use of EEG in everyday care.
Joint Commitment to Better Tools, Better Outcomes
Aswin Gunasekar, Zeto’s Founder and CEO, emphasized the shared goal: deliver tools that make a real difference in patients’ lives. By bringing together each company’s strengths—Zeto’s EEG systems and cloud platform with Firefly’s BNA™ analytics—the partnership aims to expand access and elevate the practical capabilities of EEG technology.
About Firefly Neuroscience
Firefly (NASDAQ: AIFF) builds AI solutions to improve brain health for people with neurological and mental disorders. Its core innovation, the FDA-cleared Brain Network Analytics (BNA™), supports diagnosis and treatment monitoring for conditions such as anxiety, depression, and ADHD. The technology is backed by more than 15 years of research and a substantial library of brainwave analytics, which helps clinicians interpret patterns and track change over time.
About Zeto, Inc.
Zeto, Inc. advances EEG brain monitoring and diagnostics with award-winning medical technologies designed for ease and access. Its wearable devices bring EEG into more clinical environments without compromising quality of care. Zeto’s cloud platform enables real-time monitoring and supports AI-driven analysis; future capabilities may include areas like depression and traumatic brain injury, reflecting the company’s continued focus on accessibility and insight.
Frequently Asked Questions
What are Firefly and Zeto doing together?
They’re integrating Firefly’s Brain Network Analytics (BNA™) with Zeto’s FDA-cleared EEG systems so clinicians can capture EEG data and access AI-driven insights within a connected workflow.
How could this help patient care?
The combination of easy-to-deploy EEG hardware and BNA™ analytics can give clinicians deeper, timelier information about brain function, which supports better diagnoses and treatment decisions.
Where can Zeto’s EEG systems be used?
The WR19 and Zeto ONE headsets are designed for diverse settings, from ICUs to outpatient clinics, supported by a cloud platform and neurologist assistance.
What does BNA™ add to EEG data?
BNA™ provides structured insight into brain network activity that can help assess conditions including anxiety, depression, and ADHD, and support ongoing treatment monitoring.
How do providers get access to these tools?
Through the partnership, Firefly will distribute Zeto’s EEG devices and cloud services, giving healthcare teams streamlined access to monitoring, analysis, and data storage.
